Ceramides are natural skin lipids with a double identity. Applied as creams, and less so taken by mouth, they strengthen the skin barrier and improve hydration in dry, aging skin. Inside the body, high blood levels signal heart and metabolic risk, driven by diet and lifestyle rather than skin products. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Ceramide risk score (CERT2) | Low-risk category (score 0–3) | Captures cardiovascular risk beyond standard lipids |
| Fasting glucose | 70–85 mg/dL | Internal ceramides drive insulin resistance |
| Fasting insulin | 2–5 µIU/mL | Early marker of insulin resistance linked to ceramide accumulation |
| Triglycerides | <80 mg/dL | Tracks with saturated-fat load and ceramide synthesis |
| Apolipoprotein B (apoB) | <80 mg/dL | Core cardiovascular risk marker complementing ceramide score |
| hs-CRP | <1.0 mg/L | Inflammation amplified by ceramide signaling |
Cadence: Reassess skin response at ~8–12 weeks for oral use; reassess metabolic and ceramide markers every 6–12 months.